Generic Dosage Classification Indication Contraindication Side Effects Nursing Intervention

Name / Trade
Name
Butamirate 1 tab, BID Antitussive Acute cough of Special CNS: dizziness. Assess cough type and
Citrate / Sinecod any etiology. Pre Precaution: GI: Nausea and frequency
and Post op cough Pregnancy and vomiting,
sodation for lactation. diarrhea. Skin: Monitor the adverse
surgical Pregnancy Risk rash reactions
procedures and Category: C
bronchoscopy Contraindication: Assess patient’s VS
Hypersensitivity to Assess sleep pattern.
drug
Teach patient:
-If cough persist 10
days + fever or chest
pain – check with
Doctor.
-Don’t exceed
recommended dose

Drink fluids but not

immediately after
dose.

Since the drug may

cause dizziness or
drowsiness, caution
patient to avoid
driving or other
activities requiring
alertness until
response to medication
is known.

Advise patient to
minimize cough by
avoiding irritants
(cigarette smoke,
fumes,
dust)
Instruct patient to
cough effectively, sit
upright and take
several deep breaths
before attempting.
Doxofylline 200mg, 1 tab Antiasthmatic & Bronchial asthma Acute MI, Nausea, vomiting Assessment for any
(MaxVit) BID COPD Preparation and pulmonary hypotension, epigastric pain, occurrence of
disease with lactation cephalalgia, epigastric pain or
spastic bronchial irritability, nausea & vomiting.
component insomnia,
tachycardia, Assess patient’s
extrasystole, respiratory rate, blood
tachypnea, sugar and urinalysis
hyperglycemia,
albuminuria Advise patient to take
meds in AM
Acetylcystine – 200mg in ½ Respiratory and Acetylcysteine is Special • Stickiness • ssess
N glass of h20 intratracheal used in adjunct Precautions: on face pretreatment
BID inhalant, Mucolytic treatment for Asthmatic • Transient respirations for
, and an Antidote. abnormally viscid patients, history unpleasant rate, depth, and
mucous of odor rhythm.
secretions present bronchospasm, • Increased • If
in acute and peptic bronchial bronchospasm
chronic ulceration. secretions occurs, stop the
bronchopulmonar Pregnancy, • Irritated treatment and
y disease and lactation. throat notify the
pulmonary physician.
Category B: • Nausea
complication of • Monitor rate,
Either animal- • Vomiting
cystic fibrosis, depth, rhythm,
tracheostomy reproduction • Rhinorrhea
and type of
care and in studies have • Skin rash
respiration
treatment of not • Facial
demonstrate • Check sputum
acetaminophen edema
d a foetal risk for color,
overdose. It is • Bronchosp
but there are consistency and
also used in the asm
no controlled amount.
prevention of • Wheezing
renal damage studies in •
from dyes given pregnant • Large
women or Patient Teachings for
during certain doses may
animal- Clients Taking
diagnostic tests produce
reproduction Acetylcysteine
like CT scan. severe
studies have nausea
shown an and • An unpleasant
adverse vomiting. odor may be
effect (other noticed during
than a initial
decrease in administration
fertility) that but disappears
was not quickly.
confirmed in • Adequate
hydration
 should be
controlled observed.
studies in • Proper coughing
women in the and deep
1st trimester breathing
(and there is techniques.
no evidence
of a risk in
later
trimesters).

Cefuroxime 75mg q 8, TIV Cephalosporin Less susceptible If the drug was Body as a • Determine
to beta lactamase tolerated it can Whole: history of
and have greater cause diarrhea, Thrombophlebitis hypersensitivity
activity against nausea, vomiting, (IV site); pain, reactions to
Haemophilus headache, or burning, cellulitis cephalosporins,
Influenzae, migraines, (IM site); penicillins, and
gonorrhea and dizziness and superinfections, history of
Lyme disease abdominal pain. positive Coombs' allergies,
test. particularly to
GI: Diarrhea, drugs, before
nausea, therapy is
antibiotic- initiated.
associated colitis. • Inspect IM and
Skin: Rash, IV injection sites
pruritus, urticaria. frequently for
Urogenital: signs of
Increased serum phlebitis.
creatinine and • Report onset of
BUN, decreased loose stools or
creatinine diarrhea.
clearance. Although
pseudomembra
nous colitis.
• Monitor I&O
rates and
pattern:
Especially
important in
severely ill
patients
receiving high
doses. Report
any significant
changes.